Trial Profile
A Study to Evaluate the Efficacy and Tolerability of a Second-line Triple Regimen of Moxifloxacin, Amoxicillin and Esomeprazole in Patients with Helicobacter Pylori Infection who Failed the Previous Treatment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Amoxicillin (Primary) ; Esomeprazole (Primary) ; Moxifloxacin (Primary)
- Indications Helicobacter infections
- Focus Adverse reactions; Therapeutic Use
- 21 Dec 2015 New trial record